000 | 01819 a2200481 4500 | ||
---|---|---|---|
005 | 20250516071056.0 | ||
264 | 0 | _c20120416 | |
008 | 201204s 0 0 eng d | ||
022 | _a1432-1335 | ||
024 | 7 |
_a10.1007/s00432-011-1113-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhai, Feng-Xian | |
245 | 0 | 0 |
_aRUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines. _h[electronic resource] |
260 |
_bJournal of cancer research and clinical oncology _cMar 2012 |
||
300 |
_a439-49 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aAzacitidine _xadministration & dosage |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCore Binding Factor Alpha 3 Subunit _xmetabolism |
650 | 0 | 4 | _aCpG Islands |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxamic Acids _xadministration & dosage |
650 | 0 | 4 | _aK562 Cells |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aLiu, Xiang-Fu | |
700 | 1 | _aFan, Rui-Fang | |
700 | 1 | _aLong, Zi-Jie | |
700 | 1 | _aFang, Zhi-Gang | |
700 | 1 | _aLu, Ying | |
700 | 1 | _aZheng, Yong-Jiang | |
700 | 1 | _aLin, Dong-Jun | |
773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 138 _gno. 3 _gp. 439-49 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00432-011-1113-y _zAvailable from publisher's website |
999 |
_c21400781 _d21400781 |